SEC filings and other documents

Hybrid care, rapid growth, and focus on quality outcomes drive industry leadership.

National mental health leader posts strong growth, raises 2026 outlook, and expands margins.

Hybrid mental health provider targets mid-teens EBITDA margins by 2028 amid strong industry growth.

Q1 revenue up 21%, EBITDA up 48%, and guidance raised on strong clinician growth and productivity.

2025 saw record revenue, margin, and cash flow growth, with strong 2026 guidance and tech investments.

Record growth in visits and EBITDA, with strong outlook and expanding operational efficiencies.

Scale, hybrid care, and tech-driven efficiency drive growth and margin expansion.

Double-digit revenue growth, record free cash flow, and raised margin guidance highlight Q2 strength.

Operational excellence and technology investments set the stage for margin expansion and growth.

Achieved record revenue, double-digit margins, and first-ever positive net income as a public company.

Achieved record revenue and margin growth in 2024, with strong 2025 outlook and new leadership.

Q3 revenue up 19% to $312.7M, net loss narrows, and Adjusted EBITDA more than doubles.